JOYCELYN MARTIN WALCOTT: Open Payments
NPI 1841953189 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 24 payments from 16 companies in 2025. Trend: 2023 $1,561 · 2024 $316 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $92 |
| Amneal Pharmaceuticals LLC | 3 | $44 |
| GENZYME CORPORATION | 1 | $44 |
| Janssen Biotech, Inc. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Aveo Pharmaceuticals, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Kite Pharma, Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $25 |
| Incyte Corporation | 1 | $25 |
Products named: KEYTRUDA, ALYMSYS, SARCLISA, FOTIVDA, Yescarta, VENCLEXTA, MONJUVI, ERLEADA.
Industry payments across TX — which companies pay providers there.
